These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 2109582)

  • 81. Characterization of clinical isolates of beta-lactamase-negative, highly ampicillin-resistant Enterococcus faecalis.
    Cercenado E; Vicente MF; Díaz MD; Sánchez-Carrillo C; Sánchez-Rubiales M
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2420-2. PubMed ID: 8891156
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Affinity of cefonicid, a long-acting cephalosporin, for the penicillin-binding proteins of Escherichia coli K-12.
    Rake JB; Newman DJ; Actor P
    J Antibiot (Tokyo); 1984 May; 37(5):572-6. PubMed ID: 6376452
    [TBL] [Abstract][Full Text] [Related]  

  • 83. AmpC and AmpH, proteins related to the class C beta-lactamases, bind penicillin and contribute to the normal morphology of Escherichia coli.
    Henderson TA; Young KD; Denome SA; Elf PK
    J Bacteriol; 1997 Oct; 179(19):6112-21. PubMed ID: 9324260
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Bacterial resistance to carbapenems.
    Livermore DM
    Adv Exp Med Biol; 1995; 390():25-47. PubMed ID: 8718600
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Antibacterial activity of ceftriaxone].
    Bergogne-Berezin E
    Rev Med Interne; 1985 Mar; 6(2):178-86. PubMed ID: 3873670
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P; Hohl P; Then RL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Interaction of cephalosporins with penicillin-binding proteins of methicillin-resistant Staphylococcus aureus.
    Truesdell SE; Zurenko GE; Laborde AL
    J Antimicrob Chemother; 1989 Apr; 23 Suppl D():13-9. PubMed ID: 2722720
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Review of the in-vitro evaluation of FCE 22101.
    Wise R; Ballard RC
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():7-16. PubMed ID: 2659572
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Effect of 7 alpha substitution of cephems on their beta-lactamase stability and affinity for penicillin-binding proteins in Morganella morganii.
    Ohya S; Yamazaki M; Sugawara S
    Antimicrob Agents Chemother; 1983 Apr; 23(4):522-5. PubMed ID: 6602587
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Mechanisms of resistance of enterococci to beta-lactam antibiotics.
    Fontana R; Canepari P; Lleò MM; Satta G
    Eur J Clin Microbiol Infect Dis; 1990 Feb; 9(2):103-5. PubMed ID: 2180705
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mode of action of ceftazidime: affinity for the penicillin-binding proteins of Escherichia coli K12, Pseudomonas aeruginosa and Staphylococcus aureus.
    Hayes MV; Orr DC
    J Antimicrob Chemother; 1983 Aug; 12(2):119-26. PubMed ID: 6413485
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.
    Watanabe N; Katsu K
    J Antibiot (Tokyo); 1993 Nov; 46(11):1707-15. PubMed ID: 8270493
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Outer membrane permeation of beta-lactam antibiotics in Escherichia coli, Proteus mirabilis, and Enterobacter cloacae.
    Sawai T; Hiruma R; Kawana N; Kaneko M; Taniyasu F; Inami A
    Antimicrob Agents Chemother; 1982 Oct; 22(4):585-92. PubMed ID: 6758687
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
    Pace J; Bertasso A; Georgopapadakou NH
    Antimicrob Agents Chemother; 1991 May; 35(5):910-5. PubMed ID: 1649574
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Penem derivatives: beta-lactamase stability and affinity for penicillin-binding proteins in Escherichia coli.
    Ohya S; Utsui Y; Sugawara S; Yamazaki M
    Antimicrob Agents Chemother; 1982 Mar; 21(3):492-7. PubMed ID: 7049076
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cefpodoxime proxetil, its in vitro antibacterial activity, affinity to bacterial penicillin-binding proteins, and synergy of bactericidal activity with serum complement and mouse-cultured macrophages.
    Yokota T; Suzuki E; Arai K
    Drugs Exp Clin Res; 1988; 14(8):495-500. PubMed ID: 3073932
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Biochemical characterization of novel tetrahydrofuranyl 1beta-methylcarbapenems: stability to hydrolysis by renal dehydropeptidases and bacterial beta-lactamases, binding to penicillin binding proteins, and permeability properties.
    Yang Y; Testa RT; Bhachech N; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2904-9. PubMed ID: 10582880
    [TBL] [Abstract][Full Text] [Related]  

  • 99. When drug inactivation renders the target irrelevant to antibiotic resistance: a case story with beta-lactams.
    Lakaye B; Dubus A; Lepage S; Groslambert S; Frère JM
    Mol Microbiol; 1999 Jan; 31(1):89-101. PubMed ID: 9987113
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Amino acid sequence homologies between Escherichia coli penicillin-binding protein 5 and class A beta-lactamases.
    Waxman DJ; Amanuma H; Strominger JL
    FEBS Lett; 1982 Mar; 139(2):159-63. PubMed ID: 7042389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.